LEOCLAN Co.,Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from LEOCLAN Co.,Ltd.'s yearly results (2022–2025), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 1 of 3. Less steady than 90% of Healthcare companies in Japan.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
1.4×Over the last 3 years its own operating cash covered its investment spending (capex) 1.4 times.
Higher than 50% of Healthcare companies in Japan.
Cash Locked Ratio
¥3For every ¥100 of sales, ¥3 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥1 tied up three years earlier.
Less money tied up than 74% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 90% of Healthcare companies in Japan.
Growth Efficiency Ratio
—Sales fell 28%
Sales fell 28% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-28% / -19%In 3 years sales changed by -28% while total assets changed by -19%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
99%Of every ¥100 the company owns, ¥99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 73% of Healthcare companies in Japan.
Tangible Net Worth Ratio
98%Of every ¥100 of net worth, ¥98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 73% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
LEOCLAN Co.,Ltd. owes ¥0.73 for every ¥1 it owns. Net profit rose 12% in the year to Sep 2025, and shrank 30% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Sep 2025.
P/E ratio
50.4Investors pay ¥50.4 for every ¥1 of LEOCLAN Co.,Ltd.'s yearly profit, higher than 91% of Healthcare companies in Japan.
P/B ratio
0.98The share price is 0.98 times LEOCLAN Co.,Ltd.'s book value per share, lower than 76% of Healthcare companies in Japan.
Market cap
¥5.7 BThe total market value of all of LEOCLAN Co.,Ltd.'s shares at today's price (share price × number of shares), smaller than 76% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥5.8 BWhat LEOCLAN Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥983.82Net worth divided by the number of shares. The share price of ¥960.00 is 1.0 times this, which is the P/B above.
Return on equity (ROE)
2.2%LEOCLAN Co.,Ltd. earned 2.2% on its shareholders' money over the last year, lower than 69% of Healthcare companies in Japan.
Owes vs Owns
0.73×LEOCLAN Co.,Ltd. owes ¥0.73 for every ¥1 it owns (moderate), higher than 88% of Healthcare companies in Japan.
Dividend yield
1.73%LEOCLAN Co.,Ltd. pays 1.73% of its share price as dividends a year, lower than 78% of dividend-paying Healthcare companies in Japan.
Revenue growth
+9%Revenue rose 9% in the year to Sep 2025, and shrank 10% a year on average over 3 years.
Profit growth
+12%Net profit rose 12% in the year to Sep 2025, and shrank 30% a year on average over 3 years.
Profit margin
0.7%LEOCLAN Co.,Ltd. keeps ¥1 of every ¥100 of revenue as net profit.
Cash quality
-0.6×Cash from LEOCLAN Co.,Ltd.'s business was -0.6× its reported profit in the year to Sep 2025 — the business used cash even though it reported a profit.
Questions
What is LEOCLAN Co.,Ltd.'s P/E ratio?
Investors pay ¥50.4 for every ¥1 of LEOCLAN Co.,Ltd.'s yearly profit, higher than 91% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For LEOCLAN Co.,Ltd.: ¥5.7 B ÷ ¥5.8 B (30 Jun 2026) = 1.0.
What is LEOCLAN Co.,Ltd.'s return on equity?
LEOCLAN Co.,Ltd. earned 2.2% on its shareholders' money over the last year, lower than 69% of Healthcare companies in Japan.
How much does LEOCLAN Co.,Ltd. owe compared with what it owns?
LEOCLAN Co.,Ltd. owes ¥0.73 for every ¥1 it owns (moderate), higher than 88% of Healthcare companies in Japan.
Does LEOCLAN Co.,Ltd. pay a dividend?
Yes. LEOCLAN Co.,Ltd. pays 1.73% of its share price as dividends a year, lower than 78% of dividend-paying Healthcare companies in Japan.
Is LEOCLAN Co.,Ltd.'s revenue growing?
Revenue rose 9% in the year to Sep 2025, and shrank 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.